Erectile dysfunction (ED) are common problem in males with lower urinary tract symptoms (LUTS).The aim of this study is to evaluate whether there is an association between PSA levels and ED or not. This study included total of 54 males aged 45-75 years old, who attended in department of urology. International Prostate Symptom Score (IPSS) was used for LUTS measurements. The International Index of Erectile Function questionnaire-5 (IIEF) was used ED measurements. We evaluate the relationship between PSA and ED or LUTS.Patients were divided into3 groups according to PSA level. Group 1: 0,1-1,3 ng/dl, group 2: 1,33,2ng/dl and group 3: 3,2-10 ng/dl. The IPSS score was 16,9 in group 1, 18,1 in group 2 and 21 in group 3. The IIEF score 16,4/14,1/13,8 respectively. The severity of ED or LUTS was associated with the PSA level. PSA showed a significant positive correlation with ED and LUTS. In group 1 patients having lowest PSA level, sexuel function was better. ED was positively correlated with LUTS.ED and LUTS were significantly and independently correlated with PSA level. PSA may be a predictor factor for ED. But, there was no significant difference between PSA level and ED. Nevertheless, multicenteric, controlled, long-term, randomized studies are needed
___
1. McVary KT. Clinical practice. Erectile dysfunction. N Engl J Med. 2007;357:2472-81.
2. Krane RJ, Goldstein I, Saenz de Tejada I. Impotence. N Engl J Med. 1989;321:1648-59.
3. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB.Impotence and its medical and psychosocial correlates: results of the MassachusettsMale Aging Study. J Urol. 1994;151(1):54-61.
4. Morley JE, Kaiser FE. Impotence: the internist’s approach to diagnosisand treatment. Adv Intern Med. 1993;38:151-68.
5. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E,O'Leary MP, Puppo P, Robertson C, Giuliano F. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7) Eur Urol. 2003;44(6):637-49.
6. Seftel AD, de la Rosette J, Birt J, Porter V, Zarotsky V, Viktrup L. Coexisting lower urinary tract symptoms and erectiledysfunction: a systematic review of epidemiological data. Int J ClinPract 2013;67(1):32-45.
7. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. Sexual function in men older than 50 years of age: results from the health professionals followup study. Ann Intern Med. 2003;139(3):161-8.
8. Roberts RO, Jacobsen SJ, Rhodes T, Girman CJ, Guess HA, Lieber MM. Natural history of prostatism: impaired health states in men with lower urinary tract symptoms. J Urol. 1997;157(5):1711-7
9. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281(6):537-44.
10. Barry MJ, Fowler FJ, Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549-57
11. Rosen, RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation ofan abridged 5-item version of the International Index of Erectile Function(IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6): 319-26.
12. Rosen RC, Riley A, Wagner G,Osterloh IH, Kirkpatrick J, Mishra A. The International Index of ErectileFunction (IIEF): A multidimensional scale for assessment if erectiledysfunction. Urology. 1997;49(6):822-30.
13. 13.Acar O and Sanlı O. PSA: History, Biochemical and Clinical Features and Isoforms. Turk Urol Sem. 2012;3:49-54.
14. Vieira JG, Nishida SK, Pereira AB, Arraes RF, Verreschi IT. Serum levels of prostatespecific antigen in normal boys throughout puberty. J Clin Endocrinol Metab. 1994;78(5):1185-7.
15. Oesterling JE. PSA leads the way for detecting and following prostate cancer. Contemp Urol. 1993;5(2):60-81.
16. Carter HB, Pearson JD, Metter EJ, Chan DW, Andres R, Fozard JL, Rosner W, Walsh PC. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA. 1992;267(16):2215-20.
17. Oesterling JE, Cooner WH, Jacobsen SJ, Guess HA, Lieber MM. Influence of patient age on the serum PSA concentration. An important clinical observation. Urol Clin North Am. 1993;20(4):671-80.
18. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of humanbenign prostatic hyperplasia with age. J Urol. 1984;132(3):474-9.